𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of choline alphoscerate (cereton) in patients with parkinson’s disease with cognitive impairments

✍ Scribed by O. S. Levin; L. A. Batukaeva; M. A. Anikina; N. A. Yunishchenko

Publisher
Springer US
Year
2010
Tongue
English
Weight
158 KB
Volume
41
Category
Article
ISSN
0097-0549

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cognitive dysfunctions and pathological
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease
✍ Gabriella Santangelo; Carmine Vitale; Luigi Trojano; Francesca Verde; Dario Gros 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

## Abstract The purpose of this study was to investigate the neuropsychological correlates of pathological gambling (PG) in Parkinson's disease (PD). Fifteen patients with PD affected by PG (identified based on DSM‐IV criteria; PD+PG) without clinically evident dementia were compared with 15 nondem

Risk factors for Parkinson's disease and
Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Parkinson's disease
✍ Andrew Siderowf; Danna Jennings; James Connolly; Richard L. Doty; Kenneth Marek; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

## Abstract Our objective was to assess the association between risk factors for Parkinson's disease (PD) and abnormal olfaction in first‐degree relatives of patients with PD. Factors including lower cigarette smoking and lower caffeine consumption have been associated with increased risk of PD. Id

CSF Aβ42 and tau in Parkinson's disease
CSF Aβ42 and tau in Parkinson's disease with cognitive impairment
✍ Thomas J. Montine; Min Shi; Joseph F. Quinn; Elaine R. Peskind; Suzanne Craft; C 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 645 KB

## Abstract We tested the hypothesis that the CSF biomarker signature associated with Alzheimer's disease (AD) is present in a subset of individuals with Parkinson's disease and Dementia (PD‐D) or with PD and Cognitive Impairment, Not Dementia (PD‐CIND). We quantified CSF Aβ~42~, total tau (T‐tau),